Pharmaceutical Packaging Market Analysis by Application, Types, Region and Business Growth Drivers by 2025

The MarketWatch News Department was not involved in the creation of this content.

Feb 04, 2021 (Market Insight Reports) —
Selbyville, Delaware Market Study Report, LLC, now offers a detailed analysis of the Pharmaceutical Packaging market in a new research that provides valuable business insights including revenue share, market size, market valuation, and regional spectrum of this vertical. The Pharmaceutical Packaging market report is an all-inclusive study of the current market trends, potential drivers & challenges, application landscape, competition situation, and SEO Contest industry-popular growth strategies, which will empower stakeholders to obtain a clear understanding of this domain.

The global Pharmaceutical Packaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 81780 million by 2025, from USD 71940 million in 2019.

Request a sample Report of Pharmaceutical Packaging Market at:

According to industry experts, the market is expected to expand considerably, recording a CAGR of XX% over the study period of 2020-2025.

Fluctuations in the demand and supply channels due to the strict lockdown measures enforced to address the COVID-19 pandemic has left several organizations in disarray. Speaking of the uncertainty of revenue in the near term, industries are expected to face challenges even once the economy arises from the pandemic. Given this, the document offers a comprehensive assessment of the numerous industry segments to help you understand the revenue prospects of the market amid COVID-19.

Key inclusions of the Pharmaceutical Packaging market report:

  • Imprint of COVID-19 pandemic on the growth matrix.
  • Major market players operating in the industry.
  • Statistical analysis of sales volume, industry size, and total market revenue.
  • An analysis of industry trends.
  • CAGR of the market as well as its sub-markets.
  • Advantages & disadvantages of the direct and indirect sales channels.
  • Growth prospects over the study period.

Pharmaceutical Packaging Market segments covered in the report:

Regional analysis: North America, Europe, Asia-Pacific, South America, Middle East and Africa

  • Regional and country-level segmentation of the industry.
  • Detailed analysis regarding of sales, returns, and market share of each region.
  • Estimates reflecting the CAGRs and revenue prospects of the listed regions over the forecast period.

Product spectrum:

  • Glass
  • Paper & Paperboard
  • Plastics
  • Others
  • Projected market share of each segment with respect to the sales and revenue.
  • Evaluation of pricing patterns.

Applications arena:

  • Blister Packaging
  • Parenteral Containers
  • Plastic Bottles
  • Pouches
  • Others
  • Estimated revenue and sales volume garnered by each application over the study period.
  • Pricing of each product segment based on the scope of their application.

Competitive terrain:

  • Becton Dickinson
  • Schott
  • Amcor
  • Gerresheimer
  • Capsugel
  • AptarGroup
  • Information including key participants of the market, manufacturing plants, and competitors of each participant.
  • Services/products offered by major companies.

The major points that are covered:

  • Overview: In this section, definition of the global Pharmaceutical Packaging Market is given along with the overview of the report in order to give a board outlook about the nature and contents of the research study.
  • Industry Players’ Strategies Analysis: The market players will be benefitted from this analysis as it will help to gain competitive advantage over their competitors.
  • Key Market Trends: In this section, in-depth analysis of the market’s latest and future trends is discussed.
  • Market Forecasts: The research analysts have provided accurate and validated values of the total market size in terms of value and volume. Other offerings in the report include consumption, production, sales, and other forecasts for the global Pharmaceutical Packaging Market.
  • Regional Analysis: Major five regions and its countries have been covered in the global Pharmaceutical Packaging market report. With the help of this analysis, market players will have estimates about the untapped regional markets and other benefits.
  • Segment Analysis: Accurate and reliable forecasts about the market share of the important segments of the Pharmaceutical Packaging market is provided.

For More Details On this Report:

Contact Us:
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: [email protected]


Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences

LANCASTER, Calif.–(BUSINESS WIRE)–Jan 26, 2021–

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a distribution agreement with the Institute of Pharmaceutical Sciences (ICF) to provide marketing, sales, and technical support to organizations within South America.

Founded in 2002, ICF is one of the largest pharmaceutical research centers in Latin America and the first commercial Brazilian laboratory to be fully certified by the Brazilian Health Regulatory Agency (ANVISA) to conduct bioavailability and bioequivalence trials. In addition to running clinical trials, ICF has expertise developing complex formulation products such as patches, nasal sprays, and inhalers for organizations globally. With a staff of over 200 highly qualified scientists, ICF will provide extensive connections throughout industry, academia, and regulatory agencies to increase awareness of GastroPlus®, ADMET Predictor®, and related services from Simulations Plus.

“Even though South America has emerged as a global manufacturing hub, with expanded research facilities for pharmaceutical and generic drug companies, the use of model-informed drug development (MIDD) is in its infancy,” said Dr. Leonardo de Souza Teixeira, CEO of ICF. “We are very happy forming this partnership with Simulations Plus to spread the knowledge and application of MIDD to support regulatory interactions.”

“Latin America is one of the fastest growing generic drug markets in the world and expected to reach $48 billion in size by 2025,” added John DiBella, Simulations Plus division president. “To capitalize on this opportunity, especially in the areas of specialty products and non-oral drug delivery systems, we are excited to be partnering with ICF, an established contract research organization (CRO) leader with strong relationships throughout Brazil and neighboring countries. We expect ICF’s expertise administering laboratory testing and clinical studies to complement our offerings to companies throughout the continent and, as a bonus, provide Simulations Plus with new research opportunities to continue advancing modeling and simulation science.”

About Simulations Plus, Inc.
Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like “believe,” “expect” and “anticipate” mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.

Follow us on Twitter | LinkedIn | YouTube

View source version on

CONTACT: Simulations Plus Investor Relations

Ms. Renee Bouche


[email protected]

Hayden IR

Mr. Cameron Donahue


[email protected]



SOURCE: Simulations Plus, Inc.

Copyright Business Wire 2021.

PUB: 01/26/2021 08:30 AM/DISC: 01/26/2021 08:31 AM